Essent Group's 15min chart triggers KDJ Golden Cross, bullish Marubozu signal.

Wednesday, Aug 20, 2025 2:13 pm ET2min read

Essent Group's 15-minute chart has triggered a KDJ Golden Cross, accompanied by a Bullish Marubozu on August 20, 2025 at 14:00. This suggests a shift in momentum towards the upside, potentially leading to further price increases. As buyers take control of the market, it is likely that bullish momentum will continue.

On August 20, 2025, at 14:00, Essent Group's 15-minute chart exhibited a KDJ Golden Cross, accompanied by a Bullish Marubozu. This technical formation suggests a significant shift in momentum towards the upside, potentially leading to further price increases. The dominance of buyers in the market indicates that bullish momentum is likely to persist.

The KDJ Golden Cross, generated by the KDJ indicator, occurs when the K line crosses above the D line. This is often seen as a bullish signal, indicating a potential shift in the stock's momentum towards the upside [1]. The Bullish Marubozu, a candlestick pattern, is characterized by a long body with no shadows above or below. This pattern suggests that the stock is being driven by strong buying pressure [1].

Essent Group's recent performance has been notable, with several companies experiencing similar technical signals. These signals follow a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in other stocks, including ASGN and Cushing NextGen [2, 3]. While these technical indicators provide insights into potential stock price movements, it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions.

As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: - Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. - Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. - CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. - Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. - Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. - Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. - Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. - Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. - JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. - Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. - Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. - MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. - Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. - Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. - Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. - Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. - Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. - Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. - Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. - Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. - PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. - Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

References:
[1] https://www.ainvest.com/news/independent-15-min-chart-triggers-kdj-golden-cross-bullish-marubozu-pattern-emerges-2508-28/
[2] https://www.ainvest.com/news/viking-15-minute
[3] https://www.ainvest.com/news/eqt-15min-chart-shows-kdj-golden-cross-bullish-marubozu-pattern-2508/

Comments



Add a public comment...
No comments

No comments yet